Open Radiofrequency Ablation Combined with Splenectomy and Pericardial Devascularization vs. Liver Transplantation for Hepatocellular Carcinoma Patients with Portal Hypertension and Hypersplenism: A Case-Matched Comparative Study

References

• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2.
   PubMed Web of Science ®Google Scholar
• EASL-EORTC. Clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–943. doi:10.1016/j.jhep.2011.12.001.
   PubMed Web of Science ®Google Scholar
• Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63(5):844–855. doi:10.1136/gutjnl-2013-306627.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Oh JW, Ahn SM, Kim KS, et al. The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism. Yonsei Med J. 2003;44(6):1053–1058. doi:10.3349/ymj.2003.44.6.1053.
   PubMed Web of Science ®Google Scholar
• Zhang X. Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: a case-control study. WJG. 2015;21(8):2358. doi:10.3748/wjg.v21.i8.2358.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Fuster J, Bruix J; Barcelona Clinic Liver Cancer (BCLC) Group. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30(6):1434–1440. doi:10.1002/hep.510300629.
   PubMed Web of Science ®Google Scholar
• Donadon M, Solbiati L, Dawson L, et al. Hepatocellular carcinoma: the role of interventional oncology. Liver Cancer (Basel). 2017;6(1):34–43. doi:10.1159/000449346.
   Web of Science ®Google Scholar
• Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004;240(5):900–909. doi:10.1097/01.sla.0000143301.56154.95.
   PubMed Web of Science ®Google Scholar
• Lu DS, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology. 2005;41(5):1130–1137. doi:10.1002/hep.20688.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology. 2007;47(1):82–89. doi:10.1002/hep.21933.
   Web of Science ®Google Scholar
• Cho YK, Kim JK, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology. 2010;51(4):1284–1290. doi:10.1002/hep.23466.
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Piscaglia F, Cescon M, et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 2013;59(2):300–307. doi:10.1016/j.jhep.2013.04.009.
   PubMed Web of Science ®Google Scholar
• Pompili M, Mirante VG, Rondinara G, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl. 2005;11(9):1117–1126. doi:10.1002/lt.20469.
   PubMed Web of Science ®Google Scholar
• Sugawara Y, Yamamoto J, Shimada K, et al. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg. 2000;190(4):446–450. doi:10.1016/s1072-7515(99)00294-x.
   PubMed Web of Science ®Google Scholar
• Cai Y, Liu Z, Liu X. Laparoscopic versus open splenectomy for portal hypertension: a systematic review of comparative studies. Surg Innov. 2014;21(4):442–447. doi:10.1177/1553350613520513.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim DY, Lim JH, et al. Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism. ANZ J Surg. 2013;83(11):865–870. doi:10.1111/j.1445-2197.2012.06241.x.
   PubMed Web of Science ®Google Scholar
• Abd EAM, Facciorusso A, Nayfeh T, et al. Immune checkpoint inhibitors for unresectable hepatocellular carcinoma. Vaccines (Basel). 2020;8(4):616. doi:10.3390/vaccines8040616.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Del PV, Crucinio N, et al. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases. World J Gastroenterol. 2016;22(16):4211–4218. doi:10.3748/wjg.v22.i16.4211.
   PubMed Web of Science ®Google Scholar
• Lin S, Hu S, Ran Y, Wu F. Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis. Transl Cancer Res. 2021;10(4):1667–1678. doi:10.21037/tcr-20-3237.
   PubMed Web of Science ®Google Scholar
• Faitot F, Allard MA, Pittau G, et al. Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation. Hepatology. 2015;62(1):179–187. doi:10.1002/hep.27864.
   PubMed Web of Science ®Google Scholar
• Samuel D, Coilly A. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation. BMC Med. 2018;16(1)113. doi:10.1186/s12916-018-1110-y.
   PubMed Web of Science ®Google Scholar
• Vodkin I, Kuo A. Extended criteria donors in liver transplantation. Clin Liver Dis. 2017;21(2):289–301. doi:10.1016/j.cld.2016.12.004.
   PubMed Web of Science ®Google Scholar
• Tomikawa M, Hashizume M, Akahoshi T, et al. Effects of splenectomy on liver volume and prognosis of cirrhosis in patients with esophageal varices. J Gastroenterol Hepatol. 2002;17(1):77–80. doi:10.1046/j.1440-1746.2002.02656.x.
   PubMed Web of Science ®Google Scholar
• Li W, Shen SQ, Wu SM, et al. Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis. Onco Targets Ther. 2015;8:2129–2137. doi:10.2147/OTT.S87580.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen Z, Yu M, et al. Safety of simultaneous hepatectomy and splenectomy in the treatment of hepatocellular carcinoma complicated with hypersplenism: a meta-analysis. Gastroenterol Res Pract. 2019;2019:9065845. doi:10.1155/2019/9065845.
   PubMed Web of Science ®Google Scholar
• Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273(3):564–571. doi:10.1097/SLA.0000000000003268.
   PubMed Web of Science ®Google Scholar
• Imai K, Yamashita YI, Yusa T, et al. Microvascular invasion in small-sized hepatocellular carcinoma: significance for outcomes following hepatectomy and radiofrequency ablation. Anticancer Res. 2018;38(2):1053–1060. doi:10.21873/anticanres.12322.
   PubMed Web of Science ®Google Scholar
• Yamashita YI, Imai K, Yusa T, et al. Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: predictors and optimal treatments. Ann Gastroenterol Surg. 2018;2(3):197–203. doi:10.1002/ags3.12057.
   PubMed Web of Science ®Google Scholar
• Kikuchi L. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival. WJG. 2014;20(6):1585. doi:10.3748/wjg.v20.i6.1585.
   PubMed Web of Science ®Google Scholar
• Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg. 2003;237(4):536–543. doi:10.1097/01.SLA.0000059988.22416.F2.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61–74. doi:10.1055/s-0030-1247133.
   PubMed Web of Science ®Google Scholar
• Buzelé R, Barbier L, Sauvanet A, Fantin B. Medical complications following splenectomy. J Visc Surg. 2016;153(4):277–286. doi:10.1016/j.jviscsurg.2016.04.013.
   PubMed Web of Science ®Google Scholar